We are live on ! Find out more
CV

Clarus Ventures Portfolio holdings

AUM $425M
1-Year Est. Return 26.13%
This Fund
S&P 500
This Quarter Est. Return
+46.51%
1 Year Est. Return
+26.13%
3 Year Est. Return
+70.29%
5 Year Est. Return
+162.11%
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$48.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSTG
1
DELISTED
NanoString Technologies, Inc.
NSTG
$79.1M 48.62%
3,959,440
– –
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$27M 16.62%
2,153,092
– –
SIEN
3
DELISTED
Sientra, Inc.
SIEN
$24.6M 15.09%
273,077
– –
ATXS
4
DELISTED
Astria Therapeutics
ATXS
$17M 10.42%
45,875
– –
VBIV
5
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$9.23M 5.67%
89,701
– –
EPIX
6
DELISTED
ESSA Pharma
EPIX
$5.83M 3.58%
106,061
– –

Similar funds

GCM
Gruss Capital Management New York $422M AUM 9.91% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return
SPC
Salient Private Client Houston, Texas $513M AUM 10.97% 1-Year Est. Return
LLC
Latimer Light Capital New York $324M AUM 25.5% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
CG
Clinton Group New York $279M AUM 4.76% 1-Year Est. Return
AAM
Amerigo Asset Management George Town, Cayman Islands $254M AUM 115.73% 1-Year Est. Return
SE
Summit Equities Parsippany, New Jersey $601M AUM 9.74% 1-Year Est. Return